CD38 and primary cutaneous T-cell non-Hodgkin lymphoma: Utilizing previously published microarray data (GSE143382; [11]) comparing CTCL and healthy human skin, our analysis reveals a substantial 4.8 log-fold increase in CD38 expression among CTCL patients in comparison to healthy controls (p < 0.0001 by Mann–Whitney test) (Fig. 1A).